Zoetis Inc. Treasury Stock, Common, Shares
Zoetis Inc. (ZTS) had Treasury Stock, Common, Shares of 87.74 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure
us-gaap:TreasuryStockCommonShares · last filed 2026-08-06
- 2026-06-30: Treasury Stock, Common, Shares 87.74M shares.
- 2026-03-31: Treasury Stock, Common, Shares 81.54M shares.
- 2025-12-31: Treasury Stock, Common, Shares 76.96M shares.
- 2025-09-30: Treasury Stock, Common, Shares 60.43M shares.
| Period end | Treasury Stock, Common, Shares | Treasury Stock, Common, Shares as first filed |
|---|---|---|
| 2026-06-30 | 87.74M shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 81.54M shares 10-Q · filed 2026-05-07 | |
| 2025-12-31 | 76.96M shares 10-Q · filed 2026-08-06 | |
| 2025-09-30 | 60.43M shares 10-Q · filed 2025-11-04 | |
| 2025-06-30 | 57.95M shares 10-Q · filed 2025-08-05 | |
| 2025-03-31 | 55.85M shares 10-Q · filed 2025-05-06 | |
| 2024-12-31 | 53.42M shares 10-K · filed 2026-02-12 | |
| 2024-09-30 | 50.34M shares 10-Q · filed 2024-11-04 | |
| 2024-06-30 | 48.08M shares 10-Q · filed 2024-08-06 | |
| 2024-03-31 | 44.94M shares 10-Q · filed 2024-05-02 | |
| 2023-12-31 | 43.50M shares 10-K · filed 2026-02-12 | 43.52M shares 10-K · filed 2024-02-13 |
| 2023-09-30 | 42.37M shares 10-Q · filed 2023-11-02 | |
| 2023-06-30 | 41.14M shares 10-Q · filed 2023-08-08 | |
| 2022-12-31 | 38.10M shares 10-K · filed 2026-02-12 | 38.08M shares 10-Q · filed 2023-08-08 |
| 2021-12-31 | 29.30M shares 10-K · filed 2025-02-13 | |
| 2020-12-31 | 26.60M shares 10-K · filed 2024-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |